Contact: Shelly Leachman
University of California - Santa Barbara
Caption: A bioengineering team at UCSB has developed synthetic platelets to deliver drugs directly to the source of disease. Indicative of the UCSB medical efforts that comprise EMBODI, the innovation could lead to major advances in medical therapies.
Credit: Peter Allen
Usage Restrictions: None
Related news release: Envisioning novel approaches for eye disease: 'The new medicine' at UC Santa Barbara